Science, the State and the City

Zusatztext At one level, the book by Owen and Hopkins provides a detailed history of the evolution of the industry in the US and the UK, the two countries which have been the most successful. The technical science behind the products is set out succinctly, and the authors chart a clear course in describing the main firms over the decades, what happened to them, where they stand now, and how they obtained their finance. It is a very good source for anyone wishing to learn about this important industry. But the main thrust of the book is analytical rather than descriptive. The aims of the authors are to explain how firms based in the US took the lead in commercialising the scientific advances, and why it has been so difficult for companies in other advanced economies to displace the Americans from their dominant position. Overall, this book is very well written and researched, and contains many interesting ideas. A very good buy. Informationen zum Autor Sir Geoffrey Owen was educated at Rugby and Balliol College, Oxford, and spent most of his career at the Financial Times, serving as industrial editor, US correspondent based in New York, deputy editor (1973-1980) editor (1980-1990) - also spent two years with the Industrial Reorganisation Corporation and three with British Leyland. He joined the LSE in 1990, served as visiting fellow in the Department of Management until 2013, teaching in the field of corporate strategy and international competition. Books include From Empire to Europe: the decline and revival of British industry since the Second Word War (HarperCollins 1999).) The rise and fall of great companies: Courtaulds and the reshaping of the man-made fibres industry (OUP 2010).Michael M. Hopkins is a Senior Lecturer and Director of Research for the Science Policy Research Unit (SPRU) at the University of Sussex. After studying Biology at Sussex, he worked in the biotechnology industry as a sales and marketing manager, selling reagents for research. He joined SPRU as a research assistant in 1997, later completing his doctoral training in Science and Technology Policy Studies. His research focuses on policies and strategies for biomedical innovation. Previous publications include A Biotechnology Managers Handbook (Woodhead Publishing 2012). Klappentext The book is about the link between science and business - how discoveries made in academic laboratories are taken up by venture capitalists and investors, and converted into products which, if they are successful, provide treatments for disease and may generate substantial returns for investors. Zusammenfassung The book is about the link between science and business - how discoveries made in academic laboratories are taken up by venture capitalists and investors, and converted into products which, if they are successful, provide treatments for disease and may generate substantial returns for investors. Inhaltsverzeichnis 1: A New Way of Making Medicines 2: The US Takes the Lead 3: The British Response 4: Investors Retreat 5: A Second Chance for UK Biotech 6: Learning from the US: An International Comparison 7: The Financing of Biotech 8: The Role of Government 9: The Persistence of Industrial Leadership ...

Autorentext
Sir Geoffrey Owen was educated at Rugby and Balliol College, Oxford, and spent most of his career at the Financial Times, serving as industrial editor, US correspondent based in New York, deputy editor (1973-1980) editor (1980-1990) - also spent two years with the Industrial Reorganisation Corporation and three with British Leyland. He joined the LSE in 1990, served as visiting fellow in the Department of Management until 2013, teaching in the field of corporate strategy and international competition. Books include From Empire to Europe: the decline and revival of British industry since the Second Word War (HarperCollins 1999).) The rise and fall of great companies: Courtaulds and the reshaping of the man-made fibres industry (OUP 2010). Michael M. Hopkins is a Senior Lecturer and Director of Research for the Science Policy Research Unit (SPRU) at the University of Sussex. After studying Biology at Sussex, he worked in the biotechnology industry as a sales and marketing manager, selling reagents for research. He joined SPRU as a research assistant in 1997, later completing his doctoral training in Science and Technology Policy Studies. His research focuses on policies and strategies for biomedical innovation. Previous publications include A Biotechnology Managers Handbook (Woodhead Publishing 2012).

Klappentext
The book is about the link between science and business - how discoveries made in academic laboratories are taken up by venture capitalists and investors, and converted into products which, if they are successful, provide treatments for disease and may generate substantial returns for investors.

Inhalt
1: A New Way of Making Medicines
2: The US Takes the Lead
3: The British Response
4: Investors Retreat
5: A Second Chance for UK Biotech
6: Learning from the US: An International Comparison
7: The Financing of Biotech
8: The Role of Government
9: The Persistence of Industrial Leadership

#	Onlineshop	Preis CHF	Versand CHF	Total CHF
1	Seller	0.00	0.00	0.00